8:45–9:00. Using PET [18F]-FDG, 11CO, and 15O-water for Monitoring Prostate Cancer During a Phase II Anti-angiogenic Drug Trial with Thalidomide. - Kurdziel,K.; Bacharach,S.; Carrasquillo,J. (Clin Positron Imaging, 2000)